Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Calabrese

Showing results (111-120 of 334) with videos related to

Pageof 34
Sort By:
Bipolar Disorders|October 20, 2019
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 studyWillie R Earley, Maria V Burgess, Barbara Khan, et al.
Neuropsychologia|January 17, 2004
Hemodynamic differences in the activation of the prefrontal cortex: attention vs. higher cognitive processingMotomi Toichi, Robert L Findling, Yasutaka Kubota, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)Michael E Thase, Wayne Macfadden, Richard H Weisler, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 25, 2007
The relationship of personality traits to substance abuse in patients with bipolar disorderGonzalo Haro, Joseph R Calabrese, Christina Larsson, et al.
Traffic Injury Prevention|September 28, 2014
The prevalence and correlates of risky driving behavior among National Guard soldiersKatherine J Hoggatt, Marta R Prescott, Emily Goldmann, et al.
The Journal of Clinical Psychiatry|May 3, 2008
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studiesRichard H Weisler, Joseph R Calabrese, Michael E Thase, et al.
Journal of Affective Disorders|December 25, 2018
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorderRoger S McIntyre, Joseph R Calabrese, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychoticsKeming Gao, David E Kemp, Elizabeth Fein, et al.
The International Journal of Neuropsychopharmacology|September 30, 2010
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorderZuowei Wang, David E Kemp, Philip K Chan, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled studyJoseph R Calabrese, Paul E Keck, Anju Starace, et al.
Pageof 34

Showing results (111-120 of 334) with videos related to

Sort By:
Pageof 34
Bipolar Disorders|October 20, 2019
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 studyWillie R Earley, Maria V Burgess, Barbara Khan, et al.
Neuropsychologia|January 17, 2004
Hemodynamic differences in the activation of the prefrontal cortex: attention vs. higher cognitive processingMotomi Toichi, Robert L Findling, Yasutaka Kubota, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)Michael E Thase, Wayne Macfadden, Richard H Weisler, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 25, 2007
The relationship of personality traits to substance abuse in patients with bipolar disorderGonzalo Haro, Joseph R Calabrese, Christina Larsson, et al.
Traffic Injury Prevention|September 28, 2014
The prevalence and correlates of risky driving behavior among National Guard soldiersKatherine J Hoggatt, Marta R Prescott, Emily Goldmann, et al.
The Journal of Clinical Psychiatry|May 3, 2008
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studiesRichard H Weisler, Joseph R Calabrese, Michael E Thase, et al.
Journal of Affective Disorders|December 25, 2018
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorderRoger S McIntyre, Joseph R Calabrese, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychoticsKeming Gao, David E Kemp, Elizabeth Fein, et al.
The International Journal of Neuropsychopharmacology|September 30, 2010
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorderZuowei Wang, David E Kemp, Philip K Chan, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled studyJoseph R Calabrese, Paul E Keck, Anju Starace, et al.
Pageof 34